This brand name is authorized in Austria, Cyprus, Estonia, Finland, Ireland, Lithuania, Poland, Romania, Tunisia, Turkey.
The drug VIEKIRAX contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
2302768XJ8 - OMBITASVIR
|
|
Ombitasvir is an nonstructural protein 5A (NS5A) inhibitor that acts by inhibiting the HCV protein NS5A. |
|
2
|
UNII
OU2YM37K86 - PARITAPREVIR
|
3
|
UNII
O3J8G9O825 - RITONAVIR
|
|
Ritonavir is an orally active peptidomimetic inhibitor of the HIV-1 and HIV-2 aspartyl proteases. Inhibition of HIV protease renders the enzyme incapable of processing the gag-pol polyprotein precursor which leads to the production of HIV particles with immature morphology that are unable to initiate new rounds of infection. Ritonavir has selective affinity for the HIV protease and has little inhibitory activity against human aspartyl proteases. Pharmacokinetic enhancement by ritonavir is based on ritonavir’s activity as a potent inhibitor of CYP3A-mediated metabolism. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| VIEKIRAX Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J05AP53 | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1674716 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 476808 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1075471 |
| PL | Rejestru Produktów Leczniczych | 100334324 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W64675001 |
| TN | Direction de la Pharmacie et du Médicament | 15623031H, 16913021H |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8680656080346 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.